ECO Animal Health Appoints Dr. Joachim Hasenmaier as Non-Executive Director - Seite 2

Current directorships/partnerships:

• Invetx, Inc.
• Minotaur Invest (holding company for IMV Technologies)
• Phagelux Agrihealth
  
  

Directorships/partnerships within the last five years:

• Heska Corporation
• Boehringer Ingelheim Corporate Center GMBH
• Boehringer AG
• Boehringer Ingelheim GMBH
• C.H. Boehringer Sohn AG & Co. KG
• Profunda Verwaltungsgesellschaft MBH & Co KG
• Boehringer Ingelheim Deutschland GMBH
• Boehringer Ingelheim Vetmedica GMBH
• Boehringer Ingelheim International GMBH
• Boehringer Ingelheim Verwaltungs GMBH
• Boehringer Ingelheim Auslandsbeteiligungs GMBH
  
  

There are no further disclosures required to be made in respect of the appointment under AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

-Ends-

For further information please contact:

ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO)	020 8447 8899
Singer Capital Markets (Nominated Adviser & Joint Broker) Phil Davies Sam Butcher	020 7496 3000
Investec (Joint Broker) Gary Clarence Lydia Zychowska	020 7597 5970
Equity Development Hannah Crowe Matt Evans	020 7065 2692
ICR Consilium (Financial PR) Mary-Jane Elliott Jessica Hodgson	020 3709 5700 [e-mail]

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

Click here for more information: https://ecoanimalhealth.com